Chronic Migraine
Neurology·MeSH: Migraine Disorders
Prevalence
15000.0 / 100K
Incidence
1500.0 / 100K/yr
8 drugs in development·5 companies·11 clinical trials
Drug Pipeline by Phase
Phase 3(4)
Preclinical(1)
| Drug | Company |
|---|---|
| abp-450 | AEON Biopharma, Inc. (AEON) |
Compare drugs
Frequently asked questions
How many drugs are in development for Chronic Migraine?
BioSniper tracks 8 drugs in development for Chronic Migraine across 5 companies.
How many clinical trials target Chronic Migraine?
There are 11 clinical trials targeting Chronic Migraine tracked by BioSniper.
What is the prevalence of Chronic Migraine?
The estimated prevalence of Chronic Migraine is approximately 15000.0 per 100,000 population.
Deep-dive into Chronic Migraine
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis